Amanote Research
Register
Sign In
ACTIVATION OF THE AhR/ARNT PATHWAY IS ASSOCIATED WITH OUTCOME OF DLBCL PATIENTS AFTER TREATED WITH RITUXIMAB
Hematological Oncology
- United Kingdom
doi 10.1002/hon.27_2631
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Cancer Research
Oncology
Hematology
Date
June 1, 2019
Authors
F. Jin
X. Yu
X. Liu
Y. Liu
H. Ma
L. Qu
Y. Dai
Publisher
Wiley
Related search
Elevated Expression of Lag3 Is Associated With Poor Outcome in Patients With DLBCL Treated With R-Chop
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Serological Markers Associated With Disease Activity in Patients With Rheumatoid Arthritis Treated With Rituximab
Journal of International Medical Research
Biochemistry
Medicine
Cell Biology
Hyponatremia Is Associated With Fluid Imbalance and Adverse Renal Outcome in Chronic Kidney Disease Patients Treated With Diuretics
Scientific Reports
Multidisciplinary
Baroreflex Impairment After Subarachnoid Hemorrhage Is Associated With Unfavorable Outcome
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Ets1 Phosphorylation at Thr38 (Pets1) Is Associated With Cell of Origin (Coo), Cell Cycle Activation, and Inferior Outcome in Diffuse Large B Cell Lymphoma (Dlbcl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Spontaneous Reperfusion After Ischemic Stroke Is Associated With Improved Outcome
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
LOW NK CELL COUNT AT DIAGNOSIS IS ASSOCIATED WITH SHORTER PFS IN ELDERLY PATIENTS WITH DLBCL TREATED WITH RCHOP AND RANDOMIZED FOR LENALIDOMIDE MAINTENANCE: A LYSA STUDY
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Vasoactive-Inotropic Score Is Associated With Outcome After Infant Cardiac Surgery
Pediatric Critical Care Medicine
Child Health
Critical Care
Pediatrics
Perinatology
Intensive Care Medicine
Maintenance Rituximab Is Associated With Improved Overall Survival in Mantle Cell Lymphoma Patients Responding to Induction Therapy With Bendamustine + Rituximab (Br)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology